Published in Gastroenterology on March 01, 1987
Calcium regulation and bone mass loss after total gastrectomy in pigs. Ann Surg (1997) 0.89
High prevalence of osteoporosis in patients with gastric adenocarcinoma following gastrectomy. World J Gastroenterol (2007) 0.85
Prevalence, pathophysiology, screening and management of osteoporosis in gastric cancer patients. J Gastric Cancer (2011) 0.82
Semiquantitative assessment of bowel habits and its relation with calcium metabolism after gastric bypass surgery: a retrospective study. J Obes (2010) 0.79
The influence of gastrectomy on the change of bone metabolism and bone density. Korean J Intern Med (2000) 0.77
Postgastrectomy osteopenia in minipigs. Ann Surg (1999) 0.75
Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res (1997) 5.69
Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest (1998) 5.03
Regulating physician-assisted death. N Engl J Med (1994) 4.84
Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest (1983) 4.53
The debate over physician-assisted suicide: empirical data and convergent views. Ann Intern Med (1998) 4.39
Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol (2000) 4.17
Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest (1999) 3.60
Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science (2002) 3.46
Clinical problem-solving. Jumping to the wrong conclusion. N Engl J Med (1998) 3.35
Substituted judgment: how accurate are proxy predictions? Ann Intern Med (1991) 3.33
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest (1999) 3.30
Asia Pacific consensus recommendations for colorectal cancer screening. Gut (2008) 3.19
The direct examination of three-dimensional bone architecture in vitro by computed tomography. J Bone Miner Res (1989) 2.89
Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med (2001) 2.81
Clinical problem-solving. When too much is too little. N Engl J Med (1996) 2.76
Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res (1998) 2.72
Voluntary death: a comparison of terminal dehydration and physician-assisted suicide. Ann Intern Med (1998) 2.68
Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med (1993) 2.65
Morals and moralism in the debate over euthanasia and assisted suicide. N Engl J Med (1990) 2.49
The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures. Calcif Tissue Int (1985) 2.44
Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. N Engl J Med (1996) 2.30
Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest (1996) 2.26
SHBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, androgen and androgen metabolite levels, and hip bone mineral density. J Clin Endocrinol Metab (2006) 2.25
The milk-alkali syndrome: current concepts. Ann Intern Med (1982) 2.24
Vitamin D and bone health in the elderly. Am J Clin Nutr (1982) 2.21
How prevalent are hospital-based palliative care programs? Status report and future directions. J Palliat Med (2001) 2.17
Educational video game for juvenile diabetes: results of a controlled trial. Med Inform (Lond) (1997) 2.12
Quantitative trait loci affecting peak bone mineral density in mice. J Bone Miner Res (1998) 2.08
The inaccessibility of advance directives on transfer from ambulatory to acute care settings. JAMA (1995) 2.07
Hypophosphatemic rickets with hypocalciuria following long-term treatment with aluminum-containing antacid. Bone (1991) 2.06
Soft-tissue calcification in uremia. Arch Intern Med (1969) 2.04
Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized, controlled trial. Ann Intern Med (1999) 2.01
Treatment of the dying in the acute care hospital. Advanced dementia and metastatic cancer. Arch Intern Med (1996) 1.91
Care of the hopelessly ill. Proposed clinical criteria for physician-assisted suicide. N Engl J Med (1992) 1.90
The association between sleep duration and obesity in older adults. Int J Obes (Lond) (2008) 1.89
Fracture risk remains reduced one year after discontinuation of risedronate. Osteoporos Int (2007) 1.79
Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab (2000) 1.77
Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures. J Bone Miner Res (1995) 1.77
Testosterone influences spatial cognition in older men. Behav Neurosci (1994) 1.75
Normative data for iliac bone histomorphometry in growing children. Bone (2000) 1.74
Bone loss and bone turnover in diabetes. Diabetes (1995) 1.74
Calcium nutrition and bone health in the elderly. Am J Clin Nutr (1982) 1.74
Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs. Am J Physiol Cell Physiol (2005) 1.70
Cardiopulmonary risk of esophagogastroduodenoscopy. Role of endoscope diameter and systemic sedation. Gastroenterology (1985) 1.69
A new method for measuring cancellous bone erosion depth: application to the cellular mechanisms of bone loss in postmenopausal osteoporosis. J Bone Miner Res (1991) 1.69
Effectiveness of Helicobacter pylori therapies in a clinical practice setting. Arch Intern Med (1999) 1.64
Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain. Fertil Steril (1995) 1.62
The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis. Calcif Tissue Int (2002) 1.61
Outcome prediction model for very elderly critically ill patients. Crit Care Med (2001) 1.60
Variation in practice of ileal intubation among diverse endoscopy settings: results from a national endoscopic database. Aliment Pharmacol Ther (2005) 1.60
The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis. Metab Bone Dis Relat Res (1982) 1.60
Pain and discomfort associated with common hospital procedures and experiences. J Pain Symptom Manage (1998) 1.58
Learning when reward is delayed: a marking hypothesis. J Exp Psychol Anim Behav Process (1979) 1.50
The cellular basis of bone remodeling: the quantum concept reexamined in light of recent advances in the cell biology of bone. Calcif Tissue Int (1984) 1.50
Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia. J Bone Miner Res (1997) 1.49
Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling. Am J Med (1995) 1.48
Barriers to completion of health care proxies: an examination of ethnic differences. Arch Intern Med (1998) 1.48
Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females. J Bone Miner Res (1988) 1.48
Age-related structural changes in trabecular and cortical bone: cellular mechanisms and biomechanical consequences. Calcif Tissue Int (1984) 1.47
Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone (2000) 1.46
Barriers to obtaining consent in dementia research: implications for surrogate decision-making. J Am Geriatr Soc (1998) 1.46
The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage. Endocrinology (1997) 1.45
Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J Clin Endocrinol Metab (1988) 1.44
Bisphosphonates: safety and efficacy in the treatment and prevention of osteoporosis. Am Fam Physician (2000) 1.43
Hyperthyroidism and hypercalcaemia. Q J Med (1970) 1.43
Older women's health: 'taking the pulse' reveals gender gap in medical care. Geriatrics (1995) 1.42
25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology (2009) 1.40
Osteomalacia: current concepts. Ann Intern Med (1978) 1.40
Operative management of thyroid abnormalities in a general medical practice hospital in sub-Saharan Africa. Trop Doct (2000) 1.39
Marked disparity between trabecular and cortical bone loss with age in healthy men. Measurement by vertebral computed tomography and radial photon absorptiometry. Ann Intern Med (1984) 1.38
Palliative care consultations: how do they impact the care of hospitalized patients? J Pain Symptom Manage (2000) 1.38
Pseudofractures in patients with low-turnover osteoporosis. West J Med (1985) 1.38
Frequency distributions of tetracycline-based measurements: implications for the interpretation of bone formation indices in the absence of double-labeled surfaces. J Bone Miner Res (1990) 1.37
Radial and vertebral bone density in white and black women: evidence for racial differences in premenopausal bone homeostasis. J Clin Endocrinol Metab (1989) 1.36
Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. Clin Ther (1999) 1.35
Body size and hip fracture risk in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Am J Med (1997) 1.34
Quantum concept of bone remodeling and turnover: implications for the pathogenesis of osteoporosis. Calcif Tissue Int (1979) 1.32
Trabecular bone architecture in the pathogenesis and prevention of fracture. Am J Med (1987) 1.29
Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial. Osteoporos Int (2014) 1.29
Osteomalacia due to vitamin D depletion: a neglected consequence of intestinal malabsorption. Am J Med (2000) 1.29
Risk factors for cardiopulmonary events during propofol-mediated upper endoscopy and colonoscopy. Aliment Pharmacol Ther (2006) 1.29
Prevalence and natural history of colonic angiodysplasia among healthy asymptomatic people. Am J Gastroenterol (1995) 1.28
Familial neonatal hypoproteinaemia with exudative enteropathy and intestinal lymphangiectasis. Arch Dis Child (1966) 1.28
Chlorothiazide-induced hypercalcemia in juvenile osteoporosis and hyperparathyroidism. N Engl J Med (1969) 1.27
Does body size account for gender differences in femur bone density and geometry? J Bone Miner Res (2001) 1.27
The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int (2014) 1.27
Dose-response relationships for alendronate treatment in osteoporotic elderly women. Alendronate Elderly Osteoporosis Study Centers. J Clin Endocrinol Metab (1997) 1.25
Bone histomorphometry: proposed system for standardization of nomenclature, symbols, and units. Calcif Tissue Int (1988) 1.25
Ethnic differences in regional bone density, hip axis length, and lifestyle variables among healthy black and white men. J Bone Miner Res (1995) 1.23
Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females. Bone (2003) 1.23
The cellular basis of bone turnover and bone loss: a rebuttal of the osteocytic resorption--bone flow theory. Clin Orthop Relat Res (1977) 1.23
Design of treatment trials for functional gastrointestinal disorders. Gut (1999) 1.23
A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis. Osteoporos Int (1991) 1.23
Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results. Osteoporos Int (2007) 1.21
A consensus-based approach to providing palliative care to patients who lack decision-making capacity. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians-American Society of Internal Medicine. Ann Intern Med (1999) 1.19
The hard task of improving the quality of care at the end of life. Arch Intern Med (2000) 1.19
Influence of age and body weight on spine and femur bone mineral density in U.S. white men. J Bone Miner Res (1990) 1.18
Primary diffuse microscopical hyperplasia of the parathyroid glands: surgical importance. Arch Surg (1976) 1.17